Geode Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Geode Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,382,968	Closed	-$1.65M	–	4981
2022 Q3	$1.65M	Buy	1,382,968 +5,258	+0.4%	+$8.2K	﹤0.01%	3155
2022 Q2	$2.48M	Sell	1,377,710 -718,988	-34%	-$1.06M	﹤0.01%	3040
2022 Q1	$4.24M	Sell	2,096,698 -115,914	-5%	-$228K	﹤0.01%	2893
2021 Q4	$6M	Buy	2,212,612 +192,041	+10%	+$710K	﹤0.01%	2792
2021 Q3	$9.01M	Buy	2,020,571 +173,838	+9%	+$837K	﹤0.01%	2527
2021 Q2	$10.7M	Buy	1,846,733 +186,391	+11%	+$1.09M	﹤0.01%	2411
2021 Q1	$11.7M	Buy	1,660,342 +309,477	+23%	+$2.08M	﹤0.01%	2261
2020 Q4	$6.48M	Buy	1,350,865 +19,247	+1%	+$97.4K	﹤0.01%	2454
2020 Q3	$7.76M	Buy	1,331,618 +95,773	+8%	+$573K	﹤0.01%	2126
2020 Q2	$8.34M	Buy	1,235,845 +320,135	+35%	+$2.42M	﹤0.01%	2036
2020 Q1	$5.82M	Buy	915,710 +198,128	+28%	+$1.59M	﹤0.01%	2055
2019 Q4	$7.48M	Buy	717,582 +918	+0.1%	+$6.67K	﹤0.01%	2210
2019 Q3	$2.82M	Buy	716,664 +23,564	+3%	+$191K	﹤0.01%	2733
2019 Q2	$10.3M	Buy	693,100 +74,089	+12%	+$1.34M	﹤0.01%	1933
2019 Q1	$15.4M	Buy	619,011 +47,007	+8%	+$1.18M	﹤0.01%	1598
2018 Q4	$10.3M	Buy	572,004 +39,369	+7%	+$804K	﹤0.01%	1774
2018 Q3	$15.6M	Buy	532,635 +20,681	+4%	+$801K	﹤0.01%	1588
2018 Q2	$23.3M	Buy	511,954 +65,557	+15%	+$3.19M	0.01%	1239
2018 Q1	$23.6M	Buy	446,397 +9,879	+2%	+$576K	0.01%	1147
2017 Q4	$29.7M	Buy	436,518 +1,206	+0.3%	+$84.3K	0.01%	987
2017 Q3	$35.9M	Buy	435,312 +9,065	+2%	+$719K	0.01%	854
2017 Q2	$39.9M	Buy	426,247 +37,390	+10%	+$2.29M	0.02%	753
2017 Q1	$24.8M	Buy	388,857 +98,407	+34%	+$5.98M	0.01%	1008
2016 Q4	$12.9M	Buy	290,450 +22,959	+9%	+$808K	0.01%	1421
2016 Q3	$9.64M	Buy	267,491 +40,467	+18%	+$868K	﹤0.01%	1520
2016 Q2	$3.11M	Buy	227,024 +9,962	+5%	+$146K	﹤0.01%	2197
2016 Q1	$4.17K	Buy	217,062 +2,712	+1%	+$57.4K	﹤0.01%	1981
2015 Q4	$7.5M	Sell	214,350 -6,366	-3%	-$411K	﹤0.01%	1579
2015 Q3	$20.3M	Buy	220,716 +30,817	+16%	+$2.67M	0.01%	879
2015 Q2	$16.7M	Buy	189,899 +6,549	+4%	+$561K	0.01%	1049
2015 Q1	$13.6M	Buy	183,350 +9,651	+6%	+$682K	0.01%	1154
2014 Q4	$9.73M	Buy	173,699 +6,145	+4%	+$323K	0.01%	1359
2014 Q3	$7.6M	Buy	167,554 +4,579	+3%	+$191K	﹤0.01%	1475
2014 Q2	$6.75M	Buy	162,975 +5,766	+4%	+$297K	﹤0.01%	1593
2014 Q1	$10.9M	Buy	157,209 +6,224	+4%	+$457K	0.01%	1195
2013 Q4	$9.1M	Buy	150,985 +53,773	+55%	+$2.92M	0.01%	1253
2013 Q3	$5.91M	Buy	97,212 +18,454	+23%	+$1.31M	﹤0.01%	1443
2013 Q2	$5.28M	Buy	+78,758	New	+$3.54M	﹤0.01%	1384